Aminosalicylates and COVID-19: Facts or Coincidences?

Affiliations

¹ Department of Gastroenterology, São João Hospital Center; Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto; Department of Clinical Pharmacology, São João Hospital University Center, Porto, Portugal.
² Centre for Health Technology and Services Research (CINTESIS); Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
³ LAQV@REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.

Comment

Fernando Magro et al. Gastroenterology. 2021 Apr.

. 2021 Apr;160(5):1884-1885.

doi: 10.1053/j.gastro.2020.05.092. Epub 2020 Jun 15.

¹ Department of Gastroenterology, São João Hospital Center; Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto; Department of Clinical Pharmacology, São João Hospital University Center, Porto, Portugal.
² Centre for Health Technology and Services Research (CINTESIS); Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
³ LAQV@REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.

No abstract available

Comment on

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Brenner EJ, et al. Gastroenterology. 2020 Aug;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032. Epub 2020 May 18. Gastroenterology. 2020. PMID: 32425234 Free PMC article.